4//SEC Filing
Smeets Guido E 4
Accession 0001209191-09-032885
CIK 0001040666other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:50 PM ET
Size
12.7 KB
Accession
0001209191-09-032885
Insider Transaction Report
Form 4
Smeets Guido E
VP, Clinical Research and CMO
Transactions
- Disposition to Issuer
Common Stock
2009-06-17$29.00/sh−6,000$174,000→ 0 total - Disposition to Issuer
Restricted Stock Units
2009-06-17−15,000→ 0 total→ Common Stock (15,000 underlying) - Award
Common Stock
2009-06-17+6,000→ 6,000 total - Disposition to Issuer
Employee Stock Options (right to buy)
2009-06-17−50,000→ 0 totalExercise: $15.72Exp: 2018-11-03→ Common Stock (50,000 underlying)
Footnotes (6)
- [F1]Represents restricted stock units that were awarded to the Reporting Person on February 13, 2009, with the vesting of such restricted stock units subject to the achievement during 2009 of certain performance objectives, as determined by the Compensation Committee of the Board of Directors of VNUS Medical Technologies, Inc. (the "Issuer"). Accordingly, the grant of these restricted stock units was not reported on Form 4. Pursuant to the Agreement and Plan of Merger, dated as of May 7, 2009, by and among Covidien Group S.a.r.l., Covidien Delaware Corp. and the Issuer (the "Merger"), these restricted stock units vested in full and were canceled at the effective time of the Merger in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes).
- [F2]Prior to the effective time of the Merger, the Reporting Person was entitled to receive one (1) share of common stock for each one (1) restricted stock unit.
- [F3]These restricted stock units vested in full and were canceled at the effective time of the Merger in exchange for the right to receive a cash payment of $29.00 for each share into which the vested restricted stock units would otherwise be convertible (without interest and less any applicable withholding taxes).
- [F4]Prior to the effective time of the Merger, the restricted stock units were scheduled to vest in four (4) successive and equal annual installments measured from November 3, 2008.
- [F5]These options were canceled at the effective time of the Merger in exchange for a cash payment of $664,000.00, representing the number of shares of Issuer's common stock underlying such options multiplied by $29.00, less the aggregate exercise price of the options.
- [F6]Prior to the effective time of the Merger, the shares subject to these options were scheduled to vest over four years, with 25% of the shares scheduled to vest on November 3, 2009, and 1/36th of the shares vesting monthly thereafter.
Documents
Issuer
VNUS MEDICAL TECHNOLOGIES INC
CIK 0001040666
Entity typeother
Related Parties
1- filerCIK 0001449430
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 8:50 PM ET
- Size
- 12.7 KB